Evidence map›Paper›PMID 41945143›Full record

ArticleArchives of microbiology2026

Unravelling the protective effects: PknJ modulates MmaA4 expression and rifampicin susceptibility in Mycobacterium bovis BCG.

Diwakar Kumar Singh, Sameer Tiwari, Kumari Kripalata, Kishore K Srivastava

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diwakar Kumar SinghBiotechnology, The Neotia University, South 24 Parganas, West Bengal, 743368, India. diwakarcdri@gmail.com.
Sameer TiwariCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Kumari KripalataCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Kishore K SrivastavaCSIR-Central Drug Research Institute, Lucknow, 226031, India. kishorecdri@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis establishes long-term persistence within the host, requiring a better understanding of the molecular processes controlling intracellular survival by altering immunological responses. The adaptability and persistence of mycobacteria are strongly influenced by post-translational modifications, particularly phosphorylation and methylation. This study examined the role of serine/threonine kinase PknJ in regulating slow growth and intracellular survival of Mycobacterium bovis BCG through its association with Rv0642c (MmaA4), a key mycolic acid methyltransferase. Deletion of pknJ led to a significant reduction in mmaA4 expression and methyltransferase activity during extracellular growth, whereas both parameters were enhanced during intracellular growth within murine macrophages. The pknJ mutant also exhibited increased sensitivity to rifampicin under extracellular conditions, accompanied by increased nitric oxide production in infected macrophages and an altered tolerance to acidic stress. Collectively, the present findings highlight a PknJ-MmaA4 regulatory axis in an avirulent mycobacterial model. This axis appears to integrate cell-wall remodelling, stress adaptation, and intracellular persistence of mycobacteria.

Indexed as

Bacterial ProteinsMethyltransferasesMycobacterium bovisProtein Serine-Threonine KinasesRifampinAnimalsGene Expression Regulation, BacterialMacrophagesMiceNitric OxidePhosphorylationBacterial ProteinsMethyltransferasesNitric OxideProtein Serine-Threonine KinasesRifampinIntracellular survival and Drug sensitivitymmaA4MycobacteriapknJProtein phosphorylation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.